HighMark Wealth Management
HighMark Wealth Management reported 579 stocks worth $323M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are IVV (27.1%), FHLC (6.1%) and EFV (4.7%). Compared with Q2 2026, the fund opened new positions in BINC, BND and XOM, added to IVV, AXGN and IJR, trimmed FHLC, EFV and IWM and sold out of XOM, OKE and SEZL.
Latest filing: what HighMark Wealth Management did in Q3 2026
vs Q2 2026Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() IVV Ishares TR | $87.3M | 27.1% | 114K | +4,043 (+4%) | 8 of 8 | |
| 2 | ![]() FHLC Fidelity Msci Health Care Index ETF | $19.7M | 6.1% | 241K | −14K (−5%) | 8 of 8 | |
| 3 | ![]() EFV Ishares TR | $15.1M | 4.7% | 190K | −8,808 (−4%) | 8 of 8 | |
| 4 | ![]() AXGN Axogen Inc | $14.4M | 4.5% | 342K | +1,100 (+0%) | 8 of 8 | |
| 5 | ![]() IWM Ishares TR | $13.9M | 4.3% | 50K | −973 (−2%) | 8 of 8 | |
| 6 | ![]() IJR Ishares TR | $12.4M | 3.9% | 91K | +1,570 (+2%) | 8 of 8 | |
| 7 | ![]() NEO Neogenomics Inc | $11.2M | 3.5% | 612K | No change | 8 of 8 | |
| 8 | ![]() VOO Vanguard S&P 500 ETF | $11.2M | 3.5% | 16K | +467 (+3%) | 8 of 8 | |
| 9 | ![]() BINC Blackrock ETF Trust II | $10.6M | 3.3% | 209K | New position | 1 of 8 | |
| 10 | ![]() BND Vanguard BD Index Fds | $9.5M | 2.9% | 135K | New position | 3 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q2 2026, gone in Q3 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
APOGEE THERAPEUTICS INC | $4.3M | 32K |
CRINETICS PHARMACEUTICALS IN | $1.4M | 39K |
![]() XOM Exxon Mobil Corp | $425K | 3,109 |
![]() OKE Oneok Inc New | $239K | 2,750 |
WEBSTER FINL CORP | $223K | 2,914 |
🔒 Free account: see all 30.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →HighMark Wealth Management 13F FAQ
What does HighMark Wealth Management own?
HighMark Wealth Management reported 579 stocks worth $323M in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are IVV (27.1%), FHLC (6.1%) and EFV (4.7%). The table above lists every position in the filing (the top 10 without an account).
What did HighMark Wealth Management buy and sell in Q3 2026?
Compared with Q2 2026: 62 new positions, 147 added to, 88 trimmed and 45 sold out. New positions include BINC, BND and XOM. It sold all of XOM, OKE and SEZL.
When will HighMark Wealth Management file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is HighMark Wealth Management's portfolio worth?
The Q3 2026 filing reports $323M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.
















